23-02-2023, 05:04

Initial Results From First Patient Dosed With Perspective

The result from first patient dosed with VMT-α-NET in India on a compassionate use basis showed favorable responses.
Globe Newswire23-02-2023, 05:04
8-02-2023, 06:03

Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce

Company’s focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging
Globe Newswire8-02-2023, 06:03